公司简称：科瑞技术 股票代码：002957 独立财务顾问：北京博星证券投资顾问有限公司 是否存在该 事项 $\frac{\pi}{2}$. $\frac{\pi}{2}$. 上市公司合规性要求 最近一个会计年度财务会计报告是否未被注册会计师出具 否定意见或者无法表示意见的审计报告 最近一个会计年度财务报告内部控制是否未被注册会计师 出具否定意见或无法表示意见的审计报告 上市后最近 36 个月内是否未出现过未按法律法规、公司章 程、公开承诺进行利润分配的情形 激励对象合规性要求 是否未包括单独或合计持有上市公司 5%以上股份的股东或 实际控制人及其配偶、父母、子女 是否最近 12 个月内未被中国证监会及其派出机构认定为不 适当人选 是否最近 12 个月内未因重大违法违规行为被中国证监会及 其派出机构行政处罚或者采取市场禁入措施 是否不存在《公司法》规定的不得担任公司董事、高级管理 人员情形 激励计划合规性要求 激励对象预留权益比例是否未超过本次股权激励计划拟授 予权益数量的 20% 激励对象为董事、高管的，股权激励计划草案是否已列明其 姓名、职务、获授数量 激励对象为董事、高管的，是否设立绩效考核指标作为激励 ...

Core Viewpoint - The company, Shenzhen Keri Technology Co., Ltd., has proposed a stock option and restricted stock incentive plan for 2025, aiming to attract and retain talent while aligning the interests of shareholders, the company, and employees [1][2]. Summary by Sections Incentive Plan Overview - The incentive plan is based on relevant laws and regulations, including the Company Law and Securities Law, and does not fall under any prohibitive conditions outlined in the regulations [1][2]. - The plan excludes directors, supervisors, senior management, and major shareholders from being incentive recipients [2][3]. Stock Options and Restricted Stocks - The total number of rights to be granted under the plan is 1.7673 million, accounting for approximately 0.42% of the company's total share capital at the time of the announcement [3][5]. - The stock options will be sourced from the company's directed issuance of A-shares, while restricted stocks will be repurchased from the secondary market [2][3]. Specifics of Stock Options - The plan includes 1.1782 million stock options, representing about 0.28% of the total share capital [3][10]. - The exercise price for the stock options is set at 12.63 yuan per share [4][14]. - The effective period for the stock options is a maximum of 36 months from the completion of the registration [4][12]. Specifics of Restricted Stocks - The plan includes 589,100 restricted stocks, accounting for about 0.14% of the total share capital [25][26]. - The grant date for the restricted stocks will be determined by the board of directors within 60 days after shareholder approval [26][27]. - The restricted stocks will have a lock-up period of 12 to 24 months before they can be sold or transferred [26][27]. Performance Assessment - The performance assessment for the stock options includes company-level targets for revenue and net profit for the years 2025 and 2026, with specific thresholds set [16][18]. - Individual performance will also be evaluated, with a grading system that affects the proportion of options that can be exercised [19][20]. Adjustment Mechanisms - The plan includes provisions for adjusting the number of stock options and their exercise prices in the event of corporate actions such as stock splits or dividends [21][22]. - The adjustments will be based on specific formulas to ensure fairness and alignment with shareholder interests [21][22]. Governance and Oversight - The shareholders' meeting is the highest authority for approving the plan, while the board of directors will manage its execution [7][8]. - The supervisory board will oversee the implementation and ensure compliance with regulations [8].

Core Viewpoint - The company addresses investor concerns regarding its stock incentive plans and dividend policies, emphasizing that the design of these plans is based on various economic factors and that there is no internal benefit transfer harming shareholder interests [1]. Group 1: Stock Incentive Plans - The company has launched three stock incentive plans since 2021, with performance targets based on revenue, absolute net profit, and net profit growth, which investors question for their coherence and achievability [1]. - The 2021 stock incentive plan was designed considering the economic situation and aimed to capitalize on market opportunities, with performance targets met in 2021 and 2022 [1]. - In 2023, the company did not meet performance targets due to strategic adjustments focusing on high-margin businesses, leading to the repurchase and cancellation of unachieved stock incentives [1]. Group 2: Dividend Policy - The company has not issued dividends since 2017 and has focused on stock incentives, with each incentive priced close to the regulatory 50% line [1]. - The company states that it cannot distribute dividends due to not meeting relevant cash dividend conditions, asserting that this does not harm shareholder interests [1]. - Future stock incentive plans will emphasize profit performance indicators to align more closely with investor needs, reflecting the company's ongoing efforts to enhance profitability [1].

Group 1 - The company is a public utility platform under the Zhongshan State-owned Assets Supervision and Administration Commission, focusing on three main sectors: water services, solid waste management, and renewable energy [1] - Water services serve as the core business, ensuring stable revenue, with a water supply capacity of 2.65 million tons per day and a market share of 94%. A potential price adjustment of 20% to 30% could increase net profit by 120 to 180 million yuan, representing a 10% to 15% increase in net profit for 2024 [1] - The solid waste management sector is expanding through acquisitions, with a projected capacity of 6,120 tons per day by 2025 [1] - In renewable energy, the company is establishing joint ventures and Pre-REITs funds, focusing on distributed photovoltaic and integrated energy storage, with approximately 500 MWp currently connected or under construction [1] Group 2 - The company holds a 10.55% stake in GF Securities, contributing significantly to its profits, with an estimated net profit of 1.199 billion yuan in 2024, of which 1.008 billion yuan comes from investment income [2] - GF Securities is expected to see improvements in performance and valuation due to structural changes and a stronger market, which could positively impact the company's overall performance [2] - The company plans to implement a three-year shareholder return plan and promote equity incentives, with a special dividend payout ratio of 53% expected in 2024 [2] - Forecasted net profits for the company from 2025 to 2027 are 1.428 billion, 1.775 billion, and 2.072 billion yuan, respectively, with a reasonable valuation estimated at 18.3 to 19.4 billion yuan, indicating a potential upside of 29% to 36% from the current market value [2]

Core Viewpoint - The announcement details the achievement of the first unlock period conditions for the 2024 restricted stock incentive plan, allowing 112 eligible participants to unlock a total of 3.849575 million shares, representing 0.7369% of the company's total share capital [1][12]. Summary by Sections Incentive Plan Overview - The 2024 restricted stock incentive plan was approved in meetings held on July 29 and August 14, 2024, with a total of 116 participants receiving 8.13565 million shares after adjustments [2][6]. - The plan's duration is up to 48 months from the date of stock grant registration [2]. Unlock Conditions - The first unlock period allows for 50% of the granted shares to be unlocked after 12 months, and the remaining 50% after 24 months [2]. - The performance assessment for the unlock conditions is based on the company's financial performance in 2024 and 2025, with specific revenue and profit growth targets set [2][4]. Performance Targets - For the first unlock period, the company must achieve either a 15% revenue growth or a 10% net profit growth compared to 2023 [3][4]. - For the second unlock period, the targets include a 26.5% revenue growth or a 15% net profit growth over the two-year period [4]. Performance Assessment Results - The company reported a revenue of 1,500.4384 million yuan for 2024, achieving a 15.41% growth, and a net profit of 209.8692 million yuan, achieving a 15.35% growth [15]. - The personal performance assessment for the participants resulted in a 100% unlock ratio for 29 individuals, while 12.325 million shares were subject to repurchase due to unmet conditions [16][17]. Approval and Legal Compliance - The board and supervisory committee confirmed that all necessary approvals and legal requirements were met for the unlock conditions to be fulfilled [19][20]. - The legal opinion from Jiangxi Huabang Law Firm affirmed the legitimacy of the unlock conditions and the eligibility of the participants [19][20].

证券简称：仟源医药 证券代码：300254 上海荣正企业咨询服务（集团）股份有限公司 关于 山西仟源医药集团股份有限公司 首次授予相关事项 之 独立财务顾问报告 目 录 一、 释义 本独立财务顾问报告中，除非文义载明，下列简称具有如下含义： 仟源医药、公司、上市公司 指 山西仟源医药集团股份有限公司 本激励计划、本计划、本次限制 指 山西仟源医药集团股份有限公司 2025 年限制性股票激励计划 性股票激励计划、股权激励计划 上海荣正企业咨询服务（集团）股份有限公司关于山西仟源医 独立财务顾问报告、本报告 指 药集团股份有限公司 2025 年限制性股票激励计划首次授予相 关 事项之独立财务顾问报告 本独立财务顾问 指 上海荣正企业咨询服务（集团）股份有限公司 公司根据本激励计划规定的条件和价格，授予激励对象一定数 限制性股票 指 量的公司股票，该等股票设置一定期限的限售期，在达到本激 励计划规定的解除限售条件后，方可解除限售流通 按照本激励计划规定，获得限制性股票的公司（含分公司及控 激励对象 指 股子公司，下同）员工 授予日 指 公司向激励对象授予限制性股票的日期，授予日必须为交易日 授予价格 指 公司授予激 ...

Core Viewpoint - Shanxi Qianyuan Pharmaceutical Group Co., Ltd. has approved the 2025 Restricted Stock Incentive Plan, granting 7.95 million shares of restricted stock at a price of 5.60 yuan per share to 171 eligible incentive objects on August 8, 2025 [1][11]. Summary by Sections Incentive Plan Overview - The total number of restricted stocks to be granted under the incentive plan does not exceed 9.15 million shares, accounting for 3.68% of the company's total share capital [2]. - The first grant involves 7.95 million shares, which is 86.89% of the total grant amount [10]. - The lock-up periods for the granted restricted stocks are set at 12, 24, and 36 months [2]. Performance Assessment Criteria - The performance assessment for the first grant period requires a net profit growth rate of no less than 25.43% in 2025 compared to 2024 [5]. - For the second grant period in 2026, the required growth rate is 71.04%, and for the third grant period in 2027, it is 133.96% [6][7]. Decision-Making Process - The decision-making process for the incentive plan has been completed, with necessary approvals obtained from the board and the compensation and assessment committee [9][11]. - The plan has been publicly disclosed for 10 days without any objections [9]. Legal and Financial Opinions - Legal opinions confirm that the incentive plan complies with relevant laws and regulations, and the conditions for granting the restricted stocks have been met [12][13]. - The independent financial advisor has also affirmed that the plan's implementation does not harm the interests of the company and its shareholders [12][13]. Financial Impact - The implementation of the restricted stock incentive plan is expected to have a limited impact on the company's financial status and operating results [11][12]. - The funds raised from the stock grant will be used to supplement the company's working capital [12].

证券代码：603276 证券简称：恒兴新材 公告编号：2025-055 江苏恒兴新材料科技股份有限公司 关于向公司 2025 年股权激励计划激励对象 首次授予限制性股票的公告 事会第十六次会议，审议通过了《关于公司<2025 年股权激励计划（草案）>及 其摘要的议案》《关于公司<2025 年股权激励计划实施考核管理办法>的议案》 等议案。公司监事会对本次激励计划的相关事项进行核实并出具了相关核查意见。 了《关于独立董事公开征集投票权的公告》（公告编号：2025-048），根据公司 其他独立董事的委托，独立董事鲍旭锋作为征集人就公司 2025 年第一次临时股 东大会审议的本激励计划相关议案向公司全体股东征集投票权。 年 8 月 1 日。公示期间，公司监事会未收到任何员工对本激励计划拟激励对象提 出的异议，并于 2025 年 8 月 2 日对外披露了《江苏恒兴新材料科技股份有限公 司监事会关于公司 2025 年股权激励计划首次授予部分激励对象名单的核查意见 及公示情况说明》（公告编号：2025-050）。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性 ...

证券代码：688337 证券简称：普源精电 公告编号：2025-035 普源精电科技股份有限公司 关于 2024 年限制性股票激励计划第一类限制性股票 第一个限售期解除限售条件成就的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次符合解除限售条件的第一类限制性股票激励对象共计 64 人，可 解除限售的第一类限制性股票数量为 214,721 股，占公司目前股本总额的 ? 本次第一类限制性股票在相关部门办理完解除限售手续后、上市流 通前，公司将发布相关提示性公告，敬请投资者注意。 普源精电科技股份有限公司（以下简称"公司"）于 2025 年 8 月 8 日召开 第二届董事会第二十八次会议和第二届监事会第二十六次会议，审议通过了《关 于 2024 年限制性股票激励计划第一类限制性股票第一个限售期解除限售条件成 就的议案》，公司 2024 年限制性股票激励计划（以下简称"本次激励计划"）第 一类限制性股票第一个解除限售期解除限售条件已成就，共计 64 名符合条件的 激励对象合计可解除限售第一类限制性股 ...

Core Viewpoint - The legal opinion letter from King & Wood Mallesons (Guangzhou) Law Firm confirms that Guangzhou Huali Technology Co., Ltd. has complied with necessary legal procedures for its 2024 stock option and restricted stock incentive plan adjustments and grants [1][14]. Group 1: Approval and Authorization - On September 20, 2024, the company held its second extraordinary general meeting of shareholders, which approved the incentive plan and authorized the board to adjust the exercise price of stock options and restricted stocks as necessary [5][6]. - The board's decisions on August 7, 2025, included adjusting the exercise price of stock options from 15.11 CNY to 14.91 CNY and the grant price of restricted stocks from 9.07 CNY to 8.87 CNY [6][10]. Group 2: Granting Conditions - The granting of stock options and restricted stocks is contingent upon the fulfillment of specific conditions, including the absence of negative audit opinions and compliance with relevant laws and regulations [12][13]. - The company confirmed that the granting conditions were met, and the designated recipients of the incentive plan are eligible under the applicable laws and regulations [12][14]. Group 3: Adjustment Procedures - The adjustment of the exercise price and grant price is in accordance with the provisions outlined in the incentive plan, which allows for adjustments in the event of capital increases, stock dividends, or other corporate actions [8][9]. - The company’s 2024 annual equity distribution plan included a cash dividend of 2.00 CNY per 10 shares, totaling approximately 29.34 million CNY, which triggered the price adjustments [9][10]. Group 4: Legal Compliance - The law firm conducted thorough due diligence and confirmed that all necessary approvals and authorizations for the adjustments and grants have been obtained, ensuring compliance with the relevant regulations [3][14]. - The legal opinion letter serves as a required document for the implementation of the incentive plan and is to be submitted to the Shenzhen Stock Exchange for public announcement [4][5].